Dr. Mel Chua: Evolution of ChemoRT Trials in Nasopharyngeal Carcinoma: A Hobbit's Journey Part
1 ビュー
• 07/12/23
0
0
埋め込む
administrator
加入者
In this second part of his lecture, Dr. Chua discusses ongoing trials in NPC, the significance of EBV titers and implications of the EBV vaccine, and his recently published trial in oligometastic NPC, among other topics.
もっと見せる
フェイスブックのコメント
SORT BY-
トップコメント
-
最新のコメント